Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Using a blow dryer in a certain way can cause localized hair damage with bubble formation inside the hair.

Ozone therapy might improve cancer treatment and reduce its side effects.

Transplant patients often get skin problems, with treatments varying by condition.

The document concludes that validated methods are needed to ensure the quality of fluconazole drugs and that new antifungal medications are necessary due to safety and resistance concerns.

People living with HIV in Turkey often have skin conditions, which are more common in advanced HIV stages and may help in diagnosing the infection.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Zidovudine may cause hair loss in advanced-stage HIV patients.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Skin issues can indicate immune system problems.

Effective symptom management in IBD improves quality of life and prevents complications.

People with HIV and low T cell counts have more hair and scalp problems.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.